BRD3308

Names

[ Name ]:
BRD3308

[Synonym ]:
BRD3308
Benzamide, 4-(acetylamino)-N-(2-amino-4-fluorophenyl)-
4-Acetamido-N-(2-amino-4-fluorophenyl)benzamide
MFCD30187588

Biological Activity

[Description]:

BRD3308 is a potent, selective HDAC3 inhibitor with IC50 of 54 nM, displays >20-fold selectivity over HDAC1 and HDAC2, >500-fold selectivity over other HDAC isoforms; attenuates PE-mediated phosphorylation of ERK, but not JNK; also activates HIV-1 transcription in the 2D10 cell line, induces outgrowth of HIV-1 from resting CD4+ T cells isolated from antiretroviral-treated, aviremic HIV+ patients ex vivo and disrupts HIV-1 latency; suppresses pancreatic β-cell apoptosis induced by inflammatory cytokines or glucolipotoxic stress, and increases functional insulin release.

[References]

References 1. Ferguson BS, et al. Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):9806-11. 2. Barton KM, et al. PLoS One. 2014 Aug 19;9(8):e102684. 3. Wagner FF, et al. ACS Chem Biol. 2016 Feb 19;11(2):363-74. View Related Products by Target HDAC

Chemical & Physical Properties

[ Density]:
1.4±0.1 g/cm3

[ Boiling Point ]:
449.9±45.0 °C at 760 mmHg

[ Molecular Formula ]:
C₁₅H₁₄FN₃O₂

[ Molecular Weight ]:
287.289

[ Flash Point ]:
225.9±28.7 °C

[ Exact Mass ]:
287.106995

[ LogP ]:
1.81

[ Vapour Pressure ]:
0.0±1.1 mmHg at 25°C

[ Index of Refraction ]:
1.689

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.